| 1000-1050 |
Registration and Coffee |
|
| 1050-1055 |
Welcome |
Mark Gumbleton/ Kerry Hood |
| 1055-1100 |
Welcome |
Elaine Ferguson (APS NFG), Steve Conlan (BSNM) |
| 1100-1230 |
Nanomedicine types |
t.b.c. |
| 1100-1130 |
Invited 1: Olivia Merkel (LMU Munich) |
LNPs |
| 1130-1200 |
Invited 2: Ioanna Mela (Cambridge Uni, BSNM) |
DNA nanotechnology |
| 1200-1230 |
Invited 3: Alan Parker (Cardiff University) |
Viral drug delivery |
| 1230-1330 |
Lunch and networking/posters |
|
| 1330-1510 |
Nanomedicines application (in vitro/analytical/experimental) |
t.b.c. |
| 1330-1400 |
Invited 4: Cameron Alexander (Uni of Nottingham) |
In vitro, polymer therapeutics |
| 1400-1430 |
Invited 5: Shareen Doak (Swansea Uni) |
Nanotoxicology/regulatory? |
| 1430-1510 |
ECR talks |
6 x 5 mins |
| 1510-1540 |
Break and posters |
|
| 1540-1720 |
Nanomedicine translation (in vivo/clinical trial/clinical therapeutics) |
t.b.c. |
| 1540-1610 |
Invited 6: Asha Patel (Imperial) |
Advanced therapies and therapeutics, regenerative medicine |
| 1610-1640 |
Invited 7: Malcolm Reid (BioNTech) |
1st cancer vaccine trial in Wales |
| 1640-1720 |
Debate or panel discussion. Suggested topic: Carriers (synthetic, natural viral) |
|
| 1720-1730 |
Closing remarks |
APS Nanomedicine Focus Group |
| 1730 onwards |
Drinks reception in PHRMY then join APS pre-conference event |
|
